These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 32030554)

  • 41. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
    Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
    Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report.
    Hsu CC; Hsu L; Hsu I; Chiu YJ; Dorjee S
    Front Endocrinol (Lausanne); 2020; 11():50. PubMed ID: 32140135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
    Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
    Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction: A systematic review and meta-analysis.
    Maleki-Hajiagha A; Razavi M; Rouholamin S; Rezaeinejad M; Maroufizadeh S; Sepidarkish M
    J Reprod Immunol; 2020 Feb; 137():103078. PubMed ID: 32006776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment.
    Csemiczky G; Harlin J; Fried G
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):954-61. PubMed ID: 12366487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
    Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
    Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve.
    Tiegs AW; Sun L; Scott RT; Goodman LR
    Fertil Steril; 2020 Apr; 113(4):788-796.e4. PubMed ID: 32147173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients.
    Sfakianoudis K; Simopoulou M; Nitsos N; Rapani A; Pantou A; Vaxevanoglou T; Kokkali G; Koutsilieris M; Pantos K
    Gynecol Obstet Invest; 2019; 84(1):99-106. PubMed ID: 30134239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis.
    Bunnewell SJ; Honess ER; Karia AM; Keay SD; Al Wattar BH; Quenby S
    Fertil Steril; 2020 Apr; 113(4):818-827.e3. PubMed ID: 32145928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
    Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
    J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.
    Tal R; Tal O; Seifer BJ; Seifer DB
    Fertil Steril; 2015 Jan; 103(1):119-30.e3. PubMed ID: 25450298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.